Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer - Université Côte d'Azur
Journal Articles Oncoscience Year : 2018

Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer

Domains

Life Sciences [q-bio] Cancer

CHLOE FERAL  : Connect in order to contact the contributor

https://hal.univ-cotedazur.fr/hal-02526788

Submitted on : Tuesday, March 31, 2020-5:47:16 PM

Last modification on : Monday, February 26, 2024-11:22:09 AM

Consult the full text

Dates and versions

hal-02526788 , version 1 (31-03-2020)

Identifiers

Cite

Laetitia Seguin, Chloe C. Feral. Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer. Oncoscience, 2018, pp.124. ⟨10.18632/oncoscience.416⟩. ⟨hal-02526788⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CNRS UNIV-COTEDAZUR
31 View
0 Download

Altmetric

Share

More